Ultrastructural integrity of human ventricular myocardium following cardioplegic arrest

Insights

Hypothermic potassium cardioplegia used during coronary bypass surgery did not harm myocardial ultrastructure in patients. This method, involving cold blood with potassium chloride, showed no adverse effects on heart muscle cells or capillaries.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Cellular Biology

Background:

  • Coronary artery bypass grafting (CABG) requires temporary interruption of blood flow.
  • Myocardial protection during aortic cross-clamping is critical.
  • Hypothermic cardioplegia is a common method for myocardial preservation.

Purpose of the Study:

  • To evaluate the ultrastructural effects of hypothermic potassium cardioplegia on human ventricular myocardium.
  • To assess potential myocardial injury induced by aortic cross-clamping and cardioplegic perfusion during CABG.

Main Methods:

  • Electron microscopy was used to examine ventricular myocardium from 6 patients before and after aortic cross-clamping.
  • A specific protocol of hypothermic cardioplegia using intermittent aortic root perfusion with cold blood and potassium chloride was employed.
  • Cross-clamp times ranged from 66 to 125 minutes.

Main Results:

  • The primary ultrastructural change observed post-bypass was myocardiocytic pooling of glycogen.
  • No abnormalities were detected in the intramyocardial capillary bed attributable to the bypass procedure or cardioplegic solution.
  • The observed glycogen pooling was not considered indicative of significant myocardial injury.

Conclusions:

  • Hypothermic potassium cardioplegia, as administered in this study, does not appear to cause ultrastructural injury to the human myocardium.
  • The method is considered safe for myocardial preservation during coronary bypass operations.
  • Further research may explore the functional implications of glycogen pooling.

Related Concept Videos